ConductScience.org, home

Paper41513618

MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer.

Chen J and 15 others. Cell Death Discov, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer. Papers, record 41513618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41513618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer.
PubMed
Journal
Cell Death Discov
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-12
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen JJing
2Lu ZZexiu
3Zhang GGuowu
4Meng DDie
5Chang CChao
6Chen JJian
7Wang BBoxuan
8Tong YYanran
9Hai YYuhang
10Lei MMing
11Yang XXingyu
12Gan YYubi
13Deng CChaoqun
14Dai PPeijin
15Liu MManranhttps://orcid.org/0000-0002-3898-6878
16Tang XXi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NSFC 82173155National Natural Science Foundation of China (National Science Foundation of China)PubMed
NSFC 82372823National Natural Science Foundation of China (National Science Foundation of China)PubMed

Source PubMed

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138335844Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.Drug Resist Updat2024https://conductscience.org/library/papers/38335844PubMed
28390097LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.Science1993https://conductscience.org/library/papers/8390097PubMed
329755127A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.Oncogene2018https://conductscience.org/library/papers/29755127PubMed
422388352Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.Cell Death Differ2012https://conductscience.org/library/papers/22388352PubMed
531837357MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.J Hepatol2020https://conductscience.org/library/papers/31837357PubMed
638791870Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.Cancers (Basel)2024https://conductscience.org/library/papers/38791870PubMed
717067392Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.Mol Cancer2006https://conductscience.org/library/papers/17067392PubMed
837243489Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?Expert Opin Ther Targets2023https://conductscience.org/library/papers/37243489PubMed
915694340Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.Mol Cell2005https://conductscience.org/library/papers/15694340PubMed
1037059065Metastasis.Cell2023https://conductscience.org/library/papers/37059065PubMed
1129872722Organotropism: new insights into molecular mechanisms of breast cancer metastasis.NPJ Precis Oncol2018https://conductscience.org/library/papers/29872722PubMed
1224122263Metastatic progression of breast cancer: insights from 50 years of autopsies.J Pathol2014https://conductscience.org/library/papers/24122263PubMed
1316322882Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.Breast Cancer Res Treat2006https://conductscience.org/library/papers/16322882PubMed
1434046360Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.Front Oncol2021https://conductscience.org/library/papers/34046360PubMed
1519573813Latent bone metastasis in breast cancer tied to Src-dependent survival signals.Cancer Cell2009https://conductscience.org/library/papers/19573813PubMed
1639221971Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39221971PubMed
178674117GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.Cell1996https://conductscience.org/library/papers/8674117PubMed
1834206026EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.Cancers (Basel)2021https://conductscience.org/library/papers/34206026PubMed
1924295852EGF receptor trafficking: consequences for signaling and cancer.Trends Cell Biol2014https://conductscience.org/library/papers/24295852PubMed
2026380552Targeting Breast Cancer Metastasis.Breast Cancer (Auckl)2015https://conductscience.org/library/papers/26380552PubMed

See all 48 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42798783Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42798783

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
MSLN10232PubTator's text mininghttps://conductscience.org/library/genes/10232NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41513618

GET https://conductscience.org/api/papers/v1/41513618/references?page=2